PharmaCyte Biotech (PMCB) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

PharmaCyte Biotech (PMCB) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

PharmaCyte Biotech

· PMCB

Dashboard

Financials

Ratios

Valuation

Statistics

4.498 M

-2.00%

General

Market Cap: $4.5M
Enterprise Value: -$13.33M
Shares Outstanding: 10,740,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -43.98%
ROE: -46.44%
ROIC: -19.51%
Current Ratio: 40.30
Debt-to-Equity: —
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.00
P/S: —
P/FCF: —
P/B: 0.15
EV/EBITDA: 2.44

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: -186.83%
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $7.01M
Operating Income: -$7.01M
Net Profit: -$16.15M

Balance Sheet

Cash and Equivalents: $17.74M
Working Capital: $30.21M
Total Assets: $36.71M
Net Debt: -$17.74M
Total Liabilities: $6.9M
Total Equity: $29.82M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$3.94M
Cash Flow from Investing: $2M
Cash Flow from Financing: $6.5M
Free Cash Flow: -$3.94M
Capital Expenditures: $0